Non‐absorbable antibiotics for managing intestinal gas production and gas‐related symptoms

@article{DiStefano2000NonabsorbableAF,
  title={Non‐absorbable antibiotics for managing intestinal gas production and gas‐related symptoms},
  author={Michele Di Stefano and Alessandra Strocchi and Simona Malservisi and Graziamaria Veneto and Antonella Ferrieri and Gino Roberto Corazza},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2000},
  volume={14}
}
Simethicone, activated charcoal and antimicrobial drugs have been used to treat gas‐related symptoms with conflicting results. 
Review article: the treatment of functional abdominal bloating and distension
Aliment Pharmacol Ther 2011; 33: 1071–1086
Clinical trial: the effects of a trans‐galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome
TLDR
This data indicates that modulation of gut microflora‐mucosal interactions may be involved in the pathogenesis of irritable bowel syndrome and may have an important role in selecting patients suitable for IBS. Expand
Treatment of Small Intestine Bacterial Overgrowth and Related Symptoms by Rifaximin
TLDR
In this paper, the efficacy of the different therapeutic approaches used is reviewed and the administration of wide-spectrum antibiotics is reviewed. Expand
Review article: small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea
TLDR
This study highlights the need to understand more fully the role of environmental factors in the development of chronic watery diarrhoea, which is one of the most common symptoms prompting GI evaluation. Expand
Germs, Gas and the Gut; the Evolving Role of the Enteric Flora in IBS
  • E. Quigley
  • Medicine
  • The American Journal of Gastroenterology
  • 2006
TLDR
The study discussed herein provides further support for a potential role for bacterial overgrowth in some patients with IBS by describing an amelioration of bloating and flatulence following a short course of the poorly absorbed antibiotic, rifaximin. Expand
Review article: abdominal bloating and distension in functional gastrointestinal disorders – epidemiology and exploration of possible mechanisms
TLDR
A large number of patients with functional bowel disorders have experienced abdominal bloating, sometimes accompanied by an increase in girth (distension), which is one of the most common and most intrusive features offunctional bowel disorders. Expand
Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome – a randomized, double‐blind, controlled study
TLDR
This study highlights the need to understand more fully the mechanism behind the immune response to probiotic bacteria in order to assess the importance of these bacteria in relieving constipation. Expand
Treatment of small intestine bacterial overgrowth.
TLDR
This paper reviews the efficacy of the different therapeutic approaches used in the treatment of small intestine bacterial overgrowth and recommends the most effective therapy that should be used. Expand
Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case–control study
Background : A higher risk of both advanced adenoma and carcinoma occurs in the sigmoid colon of patients with diverticular disease, for which bacterial carcinogens have been claimed to play a role.
Bloating and intestinal gas
TLDR
Many patients with gas-related symptoms have normal gas production but may have either impaired gas transport or transit through the gut or visceral hypersensitivity, and few studies have addressed the treatment of impairedGas transport. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 39 REFERENCES
Activated charcoal, simethicone, and intestinal gas: a double-blind study.
TLDR
Gas, although a normal constituent of the gastrointestinal tract, may result in symptoms often uncomfortable and socially embarrassing, and the source and composition of gas in the upper and lower digestive tracts is investigated. Expand
Treatment of Small Intestine Bacterial Overgrowth with Rifaximin, a Non-Absorbable Rifamycin
TLDR
This study showed that a non-absorbable derivative of rifamycin, rifaximin, has a satisfactory therapeutic efficacy in contaminated small bowel syndrome and is free of side-effects. Expand
Effects of orally administered activated charcoal on intestinal gas.
TLDR
These experiments showed that orally administered activated charcoal was effective in preventing the large increase in the number of flatus events and increased breath hydrogen concentrations that normally occur following a gas-producing meal. Expand
Effect of simethicone on lactulose-induced H2 production and gastrointestinal symptoms.
TLDR
There was no demonstrable effect of simethicone on symptoms or intestinal gas production caused by carbohydrate malabsorption in a randomized, double-blind cross-over study of healthy volunteers. Expand
Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double‐blind placebo‐controlled trial
TLDR
This double‐blind placebo‐controlled trial tested the efficacy of long term intermittent administration of a poorly absorbable antibiotic (rifaximin) in obtaining symptomatic relief in uncomplicated diverticular disease of the colon. Expand
Rifaximin versus chlortetracycline in the short‐term treatment of small intestinal bacterial overgrowth
Bacterial overgrowth of the small intestine is a condition characterized by nutrient malabsorption due to an excessive number of bacteria in the lumen of the small intestine. Current treatment isExpand
Studies of a flatulent patient.
TLDR
The physician seldom deals rationally with a patient complaining of excessive flatus, and evaluation usually conspires to underestimate the severity of the problem. Expand
Abnormal colonic fermentation in irritable bowel syndrome
TLDR
Colonic-gas production, particularly of hydrogen, is greater in patients with IBS than in controls, and both symptoms and gas production are reduced by an exclusion diet, which may be associated with alterations in the activity of hydrogen-consuming bacteria. Expand
The Relation of Passage of Gas and Abdominal Bloating to Colonic Gas Production
TLDR
The results show that symptoms commonly attributed to excess intestinal gas do not necessarily reflect increased gas production and the influence of the fiber preparations on breath hydrogen excretion in five participants. Expand
In vitro activity of rifaximin and rifampicin against some anaerobic bacteria.
  • A. Lamanna, A. Orsi
  • Medicine
  • Chemioterapia : international journal of the Mediterranean Society of Chemotherapy
  • 1984
TLDR
It turned out that the bactericidal activity of both rifamycins could be overlapped and that it equalled 100% in the case of the non-fragilis Bacteroides and Clostridium species. Expand
...
1
2
3
4
...